AI Algorithms for Predicting Genetic Disorders

By: Poojitha Nagishetti, Department of Computer Science and Engineering (Data Science), Student of Computer Science and Engineering (Data Science), Madanapalle Institute of Technology and Science, Angallu,517325, Andhra Pradesh. poojimurali2330@gmail.com

Abstract –

Congenital diseases, which are diseases that originate from the abnormalities of a person’s genome, are considered difficult and diverse diseases to handle in the health sector. Using AI devices, the genomic research of the mentioned disorders has been enhanced in terms of accuracy and speed for delineating the likely ailments in the patient population. This article discusses the outcomes of using machine learning, deep learning, and natural language processing for the prognosis of gene-related diseases. It explores the techniques, uses, and possibilities for change of those technologies in the early diagnosis, in the individualized medicine, in prenatal testing and drug development. However, there are two overarching issues that emerge from these advances: data quality issue, interpretability issue of the generated models, ethical issues, as well as the integration of models into the clinical /real world setting. It is important to mitigate these challenges to enhance the effectiveness of using AI in genomics to enhance effective solution delivery towards patients and health care.

Keywords – Genetic Disorder, Artificial Intelligence, Genomic Data, Personalized Medicine.

Introduction –

Genetic diseases are a kind of diseases which are caused due to variation in a person’s genes and are widespread in the global context[1]. These include chromosomal disorders which are inherited or occur due to new mutations include simple genetic disorders for example cystic fibrosis and polygenic disorder involving genes and environment for example heart diseases and diabetes. The diagnosis of genetic disorders on time is vital since the treatment and management of these disorders will depend on the results. However, there are various diagnostic methods mostly conventional methods which time consuming, labor-intensive, and expensive.

Integrating AI technology is currently a revolution in different fields with health being one of the most affected. Next, in warm up, genomics stands to benefit substantially through the use AI as this is an area that involves analysis of large amounts of genetic information[2], identification of patterns and predictions that AI can perform to staggering degrees of accuracy. This paper reveals that through the application of machine learning (ML), deep learning (DL), and natural language processing (NLP)[3], AI can improve the genetic disorder forecasting and diagnosis, resulting in improved patient outcomes and improved health care management politics.

This article gives a detailed picture of the AI algorithms used to predict the genetic disorders. It deals with the approaches of basic ML and DL algorithms, their examples in genomics, and the opportunities and issues of applying AI in medicine[4]. The role is to provide some insight into the future of the subject of Genomic medicine empowered by the advancements in AI.

Overview of Genetic Disorders –

Hereditary diseases or congenital anomaly entails an ailment which affects the physical structure of a person and can be attributed to a change of the genotypes of an individual either inherited from his or her parents or can be attained at any time in the life span of the patient[5]. The above abnormalities can therefore present themselves in rather simple forms which include single gene changes through to more complex forms which include multiple gene and multiple gene-environment interfaced conditions[6]. Thus, it is important to get the knowledge about the ‘kind’ of genetic disorders and how they can be classified to respond both to identification and cure methods and their rationale and effectiveness.

1. Single-Gene (Mendelian) Disorders: Mendelian genetically disorder is gene root and may be categorized to be monogenic because it occurs in one gene. Its types could be autosomal dominant genetic disorders, autosomal recessive genetic disorders, and sex-linked genetic disorders. Examples of single-gene disorders include: The following are some of the diseases that are genetic and are because of one gene:

  • Cystic Fibrosis: A genetic disorder characterized by the following characteristics: the disease is inherited through the autosomal recessive pattern; it is because of a mutation of the gene known as CFTR; the individuals affected by this disease experience thick and abundant sticky mucus that affects the respiratory and digestive tracts.
  • Sickle Cell Anemia: A genetic disease that is an autosomal recessive trait carried by a hidden allele in the HBB gene; produces a hemoglobin that strengthens the red blood cells and makes them elongated.
  • Huntington’s Disease: A Progressive Neurological Disorder, Which Is Passed Down by Inheritance and Is Due to The Mutations in The HTT Gene, Begins in Childhood.

2. Chromosomal Disorders:

Chromosomal disorders mean the structural or numerical modifications that happens in the chromosome. Such as not having some chromosomes at all, or having two of the some instead of one, or, on the contrary, having three instead of two. Examples of chromosomal disorders include Here are some of the chromosomal disorders:

  • Down Syndrome: This arose from trisomy 21, in which the child received not two as is standard, but three copies of chromosome 21; they develop learning disorders, which might slow his or her learning.
  • Turner Syndrome: It is one of the disorders that tend to occur in females with one normal X chromosome and the other sex chromosome missing or only partially developed; the disorder impacts the growth of the body and the female reproductive system.
  • Klinefelter Syndrome: It is a disorder in males characterized by a chromosomal condition where they have an extra X chromosome; have small genitals and cannot procreate.

3. Complex Disorders:

The dynamic genetic or the polygenic diseases can be described according to the ones which are brought through the multiple genes of which are not necessarily of the similar type[7]. Such diseases do not exhibit the Mendelian inheritance and superimposed on this factor is the lifestyle and the environment. Examples of complex disorders include Some of the common complex disorders include:

  • Heart Disease: Biopsy: From the genes the person receives from his parents and the person’s lifestyle, feeding system, exercising regime and smoking.
  • Diabetes: Quite an obvious chronic disease, inherited to at least a moderate extent and a portion of it is caused by the environment and systematically associated with insulin and glucose.
  • Autism Spectrum Disorder (ASD): Schizophrenia is a biochemical disease of the brain with multiple genes and causative factors are attributed to environment, and reality testing, the victims especially have a lot of problems when it comes to social relations and communication. Figure 1 shows the different AI techniques are integrated into a cohesive workflow for predicting genetic disorders.
Diagram of a central integration hub

Description automatically generated
Figure 1: Workflow of different AI techniques are integrated for predicting genetic disorders.

The Role of AI in Genomics –

Informatics has played a major role in the field of genomics by equally boosting the analysis of multiple layers of genetic information using Artificial Intelligence (AI)[8]. Two categories of AI- ML/DL have been very useful in analysis of large data sets and recognition of pattern and correlation hence leading to more accurate predictions of genetic disorders. SVM and Random Forests are employed to classify the genotype data and identify the biomarkers for the diseases, on the hand, CNNs and RNNs show a higher performance in analyzing the genomics sequence and feature the structural variations. Moreover, the Natural Language Processing (NLP) techniques help in data mining from scientific articles and patient records adding deep knowledge to the AI decision-making process. With the help of these progressive AI techniques, genomics is placing towards higher, appropriate, and specific diagnostic and averaging techniques hence helpful for the genetic treatment of patients and for the advancement of genetic medicine.

Diagnosis and Challenges –

AI technology in the diagnosis of genetic disorders provides a highly efficient diagnosis and analysis speed, high accuracy, and complete detection, However, several issues are related to AI technology. The applications of the AI in diagnosis have been transformative with the use of; predictive modeling, genomic sequencing, variant annotation, and integration of multitopic data. However, quality and availability of genetic data remain major concerns because broken information flow and sequencing errors hinder the model. Moreover, the current algorithms must be explained to be clinically approved and thus needs to have analysis methods for complex models. Data protection and genetic discrimination are some of the areas that should not be overlooked when dealing with artificial intelligence to avoid unaudited results. Also, the solution to incorporating AI into clinical processes entails multi-disciplinary work involving researchers in AI, geneticists, and clinicians. Nevertheless, the AI has a significant opportunity to augment the early diagnosis and develop the individual treatment plans in genomics, which will open a new horizon in the healthcare field and boost the patient care systems. Table 1 offers a concise overview of the workflow and the role of each component, making it easier for readers to understand how AI techniques are integrated to predict genetic disorders.

Table 1: Concise overview of the workflow and the role of each component

Component

Role

Description

Data Sources

Collecting genetic data

Diverse sources such as genomic sequences, patient medical records, and scientific literature.

Machine Learning

Classifying genetic data

Algorithms like SVM, Random Forest, and Gradient Boosting for identifying disease-associated markers.

Deep Learning

Analyzing genomic sequences

Techniques like CNNs for structural variations and RNNs for sequential data modeling.

Natural Language Processing

Extracting information from text

NLP for analyzing scientific literature, clinical notes, and genetic reports to enrich data analysis.

Predictive Model Output

Providing diagnostic predictions

Outputs from AI models, including risk scores and probabilities.

Model Interpretability

Ensuring transparency and trust

Tools like SHAP values and feature importance graphs to visualize and understand AI model predictions.

Clinical Decision-Making

Integrating AI predictions with clinical expertise

Using AI-driven insights to make informed decisions and personalized treatment plans for patients.

Future Directions –

Several new advanced in the application of the AI for the predictions on genetic disorder will be made in the future I the areas such as increasing the ability of coping with the incoming data, increasing the understanding of the model, and establishment of certain special services called precision medicine[9]. AI will continue to use multi-omics data in the future as a cost-effective solution for studying the diseases and for having the genomic data of the patient for the fast diagnosis and treatment. The elimination of this problem in the further improvement in the explainable AI will have positive effects on the implementation of the models of complex structures within the clinics because the users are able to comprehend the outcomes and the methods used. The security of data in the future shall remain a major endeavor due to ethical impacts as well as utilization of genetic particulars which, in turn, may warrant stringent ethical standards together with competent legislation[10]. The use of AI in the process of drug discovery will lead to the improvement of the speed at which new cures are produced and made available to the public The general utilization of the advanced tools in clinics, or integration of the global research data-sharing system, will also contribute to the enhancement of the process and spread of the tools[11]. Such developments are likely to announce dramatic improvements in preliminary diagnose and treatment and overall improvement of lives of the patients with the genetic disorders.

Conclusion –

AI, the modern possible impact in the diagnosis of genetic disorders as one of the modern tools for fast diagnosis and individual approach to the treatment. Machine learning using AI improves the extraordinary genetic information with the aid of deep learning and natural language processing, thus assisting in recognizing patterns related to the disease and subsequently, in identifying the approaches to diagnosis and treatment. However, as we proceed with the advancement of the use of machine learning in solving kidney related tasks, the following challenges have emerged. To provide the solution for these problems is crucial for achieving the goals of artificial intelligence in genomics. Due to technology improvements, the AI shall greatly assist in the creation of innovations in early diagnosis, unique treatment and patient care for an enhanced genomic medicine and health status.

References –

  1. K. A. Frazer, S. S. Murray, N. J. Schork, and E. J. Topol, “Human genetic variation and its contribution to complex traits,” Nat. Rev. Genet., vol. 10, no. 4, pp. 241–251, Apr. 2009, doi: 10.1038/nrg2554.
  2. G. Novakovsky, N. Dexter, M. W. Libbrecht, W. W. Wasserman, and S. Mostafavi, “Obtaining genetics insights from deep learning via explainable artificial intelligence,” Nat. Rev. Genet., vol. 24, no. 2, pp. 125–137, Feb. 2023, doi: 10.1038/s41576-022-00532-2.
  3. S. Quazi, “Artificial intelligence and machine learning in precision and genomic medicine,” Med. Oncol., vol. 39, no. 8, p. 120, Jun. 2022, doi: 10.1007/s12032-022-01711-1.
  4. S. Brasil, C. Pascoal, R. Francisco, V. dos Reis Ferreira, P. A. Videira, and G. Valadão, “Artificial Intelligence (AI) in Rare Diseases: Is the Future Brighter?,” Genes, vol. 10, no. 12, Art. no. 12, Dec. 2019, doi: 10.3390/genes10120978.
  5. C. Caudai et al., “AI applications in functional genomics,” Comput. Struct. Biotechnol. J., vol. 19, pp. 5762–5790, Jan. 2021, doi: 10.1016/j.csbj.2021.10.009.
  6. L. Triyono, R. Gernowo, P. Prayitno, M. Rahaman, and T. R. Yudantoro, “Fake News Detection in Indonesian Popular News Portal Using Machine Learning For Visual Impairment,” JOIV Int. J. Inform. Vis., vol. 7, no. 3, pp. 726–732, Sep. 2023, doi: 10.30630/joiv.7.3.1243.
  7. C.-Y. Lin, M. Rahaman, M. Moslehpour, S. Chattopadhyay, and V. Arya, “Web Semantic-Based MOOP Algorithm for Facilitating Allocation Problems in the Supply Chain Domain,” Int. J. Semantic Web Inf. Syst. IJSWIS, vol. 19, no. 1, pp. 1–23, Jan. 2023, doi: 10.4018/IJSWIS.330250.
  8. Ó. Álvarez-Machancoses, E. J. DeAndrés Galiana, A. Cernea, J. Fernández de la Viña, and J. L. Fernández-Martínez, “On the Role of Artificial Intelligence in Genomics to Enhance Precision Medicine,” Pharmacogenomics Pers. Med., vol. 13, pp. 105–119, Mar. 2020, doi: 10.2147/PGPM.S205082.
  9. S. S. Band, S. Ardabili, A. Mosavi, C. Jun, H. Khoshkam, and M. Moslehpour, “Feasibility of soft computing techniques for estimating the long-term mean monthly wind speed,” Energy Rep., vol. 8, pp. 638–648, Nov. 2022, doi: 10.1016/j.egyr.2021.11.247.
  10. R. S. Vilhekar and A. Rawekar, “Artificial Intelligence in Genetics,” Cureus, vol. 16, no. 1, p. e52035, doi: 10.7759/cureus.52035.
  11. M. Moslehpour, K. Y. Chau, A. Dadvari, B.-R. Do, and V. Seitz, “What Killed HTC and Kept Apple Alive? Brand Sustainability Comparison of Two Asian Countries,” Sustainability, vol. 11, no. 24, Art. no. 24, Jan. 2019, doi: 10.3390/su11246973.
  12. Nahar, K. M., Banikhalaf, M., Ibrahim, F., Abual-Rub, M., Almomani, A., & Gupta, B. B. (2023). A rule-based expert advisory system for restaurants using machine learning and knowledge-based systems techniques. International Journal on Semantic Web and Information Systems (IJSWIS), 19(1), 1-25.
  13. Chui, K. T., Gupta, B. B., Jhaveri, R. H., Chi, H. R., Arya, V., Almomani, A., & Nauman, A. (2023). Multiround transfer learning and modified generative adversarial network for lung cancer detection. International Journal of Intelligent Systems, 2023(1), 6376275.

Cite As

Nagishetti P. (2024) AI Algorithms for Predicting Genetic Disorders, Insights2Techinfo, pp.1

74210cookie-checkAI Algorithms for Predicting Genetic Disorders
Share this:

Leave a Reply

Your email address will not be published.